- Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845–51.
- Slavin M, Bowden R, Osborne B, Adams R, Levenstein M, Feldman A, et al. Fluconazole in prevention of Candidainfections in patients underlying bone marrow transplantation. J Infect Dis 1995; 163: 1131–6.
- Hansen JA, Goodey T, Martin PJ, Appelbaum FA, Anaselti C. Fungaemia in bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998; 338: 962–5.
- Krcmery V Jr, Trupl J, Kunova A. Nosocomial breakthrough fungemia during antifungal prophylaxis in 41 cancer patients. J Antimicrob Chemother 1998; 41: 373–80.
- Krcmery V, Spanik S, Kunova A, Trupl J. Breakthrough fungaemia appearing during empiric therapy with Amphotericin B. Chemotherapy 1997; 43: 367–70.
- Krcmery V. Breakthrough candidaemia due to Candida tropicalis in cancer children. Acta Paediatr 1994; 22: 113–5.
- Rex J, Rinaldi MG, Pfaller MA. Resistance of Candida spp. to fluconazol. Antimicrob Agents Chemother 1995; 39: 1–8.
- Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1274–7.
- Wingard JR, Merz WG, Rinaldi MG, Miller CB, Karp JE, Saral R. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother 1993; 37: 1847–9.
- Blomberg E, Rebioli A. Failure of systemic empiric therapy with Amphotericin B. Clin Infect Dis 1996; 22: 462–6.
- Bille J, Glauser MP. Evaluation of the susceptibility of pathogenic Candida species to fluconazole. Eur J Clin Microbiol Infect Dis 1997; 16: 924–8.
- Expert Panel on Management of Candidiasis, Edwards SJ. International conference for the development of a course on the management and prevention of severe candidal infections. Clin Infect Dis 1997; 25: 43–59.
Breakthrough Candidaemias During Empirical Therapy with Fluconazole in Non-cancer and Non-HIV Adults Caused by In Vitro-susceptible Candida Spp.: Report of 33 Cases
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.